VERTEX PHARMACEUTICALS INC / MA Retained Earnings 2009-2026 | VRTX
What is retained earnings?
Retained earnings represent the cumulative net income that has been reinvested in the business rather than distributed as dividends to shareholders.
What is VERTEX PHARMACEUTICALS INC / MA's current retained earnings?
VERTEX PHARMACEUTICALS INC / MA (VRTX) annual retained earnings for 2025 was $13.56B, a 41.15% increase from 2024. VERTEX PHARMACEUTICALS INC / MA retained earnings for the quarter ending March 31, 2026 was $14.59B.
What was VERTEX PHARMACEUTICALS INC / MA's retained earnings in 2024?
VERTEX PHARMACEUTICALS INC / MA annual retained earnings for 2024 was $9.61B, a 5.28% decline from 2023.
What was VERTEX PHARMACEUTICALS INC / MA's retained earnings in 2023?
VERTEX PHARMACEUTICALS INC / MA annual retained earnings for 2023 was $10.14B, a 55.49% increase from 2022.
What is VERTEX PHARMACEUTICALS INC / MA's 5-year retained earnings CAGR?
VERTEX PHARMACEUTICALS INC / MA retained earnings grew at a compound annual growth rate (CAGR) of 73.65% from FY2020 to FY2025, going from $858.7M to $13.56B over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $13.56B | +41.2% | 10-K |
| FY2024 | $9.61B | -5.3% | 10-K |
| FY2023 | $10.14B | +55.5% | 10-K |
| FY2022 | $6.52B | +103.8% | 10-K |
| FY2021 | $3.20B | +272.7% | 10-K |
| FY2020 | $858.7M | +146.3% | 10-K |
| FY2019 | $-1.85B | +38.0% | 10-K |
| FY2018 | $-2.99B | +41.6% | 10-K |
| FY2017 | $-5.12B | +4.7% | 10-K |
| FY2016 | $-5.37B | -2.1% | 10-K |
| FY2015 | $-5.26B | -11.8% | 10-K |
| FY2014 | $-4.71B | -18.6% | 10-K |
| FY2013 | $-3.97B | -12.6% | 10-K |
| FY2012 | $-3.52B | -3.1% | 10-K |
| FY2011 | $-3.41B | +0.9% | 10-K |
| FY2010 | $-3.44B | -28.1% | 10-K |
| FY2009 | $-2.69B | - | 10-K |